BD (NYSE: BDX) recently issued a medical device correction later related to its Bard subsidiary's Rotarex atherectomy system.

RapidAI announced that it received FDA 510(k) clearance for its Lumina 3D automated 3D imaging reconstruction solution.

Overall complication rates were similar to those seen with transfemoral access, however, and patients liked it better.

A model incorporating 29 newly identified retinal vascular parameters linked to stroke risk outperformed a model with traditional risk factors for stroke.